Other news
News
Other news
Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I
Read full storyOther news
Paige Secures Financing from KKR for Total Series C Funding Round of Over $125 Million
Read full storyOther news
FDA Authorizes Cue Health's COVID-19 Test for At-Home and Over The Counter Use
Read full storyOther news
ViaCyte and Gore Expand Collaboration to Develop Novel Membrane and Device Technologies that Enhance Delivery of Cell Replacement Therapies for Diabetes
Read full storyJNJ Press releases
Gathering Innovation Strength to Capture New Value Johnson & Johnson is Recognized as the First Foreign-Funded Open Innovation Platform by the Shanghai Municipal Government
Read full storyOther news
ViaCyte Appoints Michael Yang President and CEO and Provides Company Update
Read full storyOther news
Paige Announces Series C Funding Round of $100 Million to Accelerate Transformation of Digital Pathology
Read full storyOther news
4 Ways Johnson & Johnson Advanced Much-Needed Healthcare Innovations Amid the Pandemic
Read full storyOther news
Aro Biotherapeutics Announces $88 Million Series A Financing to Advance Development of Centyrin-Targeted Genetic Medicines
Read full storyOther news
ONL Therapeutics Closes $46.9 Million in Series B Financing to Advance ONL1204 into Three Retinal Disease Indications
Read full storyOther news
XWPharma Names Michael M. Morrissey, PhD to Board of Directors
Read full storyOther news
Big Data Institute announces collaboration with Janssen to advance understanding of human genetic signatures
Read full storyOther news
Cue’s Molecular, Point-of-Care COVID-19 Tests Deployed to Five States in HHS and DOD Pilot Program
Read full storyOther news